Zai Lab
ZLAB
81 hedge funds and large institutions have $1.22B invested in Zai Lab in 2019 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 32 increasing their positions, 13 reducing their positions, and 13 closing their positions.
146% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 13
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
95% more capital invested
Capital invested by funds: $626M → $1.22B (+$597M)
85% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 13
16.49% more ownership
Funds ownership: 36.5% → 52.98% (+16%)
16% more funds holding
Funds holding: 70 → 81 (+11)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $251K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$96.9M |
| 2 |
HH
HSG Holding
Na,
Hong Kong
|
+$85.8M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$60.2M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$27.2M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$26.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$6.84M |
| 2 |
PC
Polar Capital
London,
United Kingdom
|
-$5.16M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$4.65M |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$2.32M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
-$2.11M |
ZLAB Hedge Fund Activity: Q2 2019 in Review
81 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Zai Lab (ZLAB) for Q2 2019, worth a combined $1.22B — up 95% from $626M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new ZLAB positions and 13 closed out — a net gain of 11 holders — while 32 added to existing stakes and 13 trimmed.
The largest buyer was Wellington Management Group, opening a new position worth an estimated $96.9M. The largest seller was OrbiMed, cutting an estimated $6.84M.
- 81 institutional investors held Zai Lab (ZLAB) as of Q2 2019, up from 70 in Q1 2019.
- Funds reported $1.22B of Zai Lab stock for Q2 2019, up 95% quarter-over-quarter.
- 24 funds opened new Zai Lab positions in Q2 2019 and 13 closed out, a net change of +11 holders.
- The largest Zai Lab buyer in Q2 2019 was Wellington Management Group, an estimated $96.9M added.
- The largest Zai Lab seller in Q2 2019 was OrbiMed, an estimated $6.84M sold.
Based on aggregated 13F filings for Q2 2019.